Gene Sung1, Nichole Bosson2,3,4, Amy H Kaji2,3, Mark Eckstein5, David Shavelle6, William J French3,7, Joseph L Thomas3,7, William Koenig4, James T Niemann2,3. 1. Department of Neurology, Keck School of Medicine of the University of Southern California, 1520 San Pablo St, Ste 3000, Los Angeles, CA, 90033, USA. gsung@usc.edu. 2. Department of Emergency Medicine, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA. 3. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 4. Los Angeles County Emergency Medical Services Agency, Los Angeles, CA, USA. 5. Department of Emergency Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. 6. Department of Cardiology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. 7. Department of Cardiology, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA.
Abstract
OBJECTIVE: Therapeutic hypothermia (TH) improves neurologic outcome in patients resuscitated from ventricular fibrillation. The purpose of this study was to evaluate TH effects on neurologic outcome in patients resuscitated from a non-shockable out-of-hospital cardiac arrest rhythm. DESIGN AND SETTING: This is a retrospective cohort study of data reported to a registry in an emergency medical system in a large metropolitan region. Patients achieving field return of spontaneous circulation are transported to designated hospitals with TH protocols. PATIENTS: Patients with an initial non-shockable rhythm were identified. Patients were excluded if awake in the Emergency Department or if TH was withheld due to preexisting coma or death prior to initiation. The decision to initiate TH was determined by the treating physician. MEASUREMENTS: The primary outcome was survival with good neurologic outcome defined by a cerebral performance category of 1 or 2. MAIN RESULTS: Of the 2772 patients treated for cardiac arrest during the study period, there were 1713 patients resuscitated from cardiac arrest with an initial non-shockable rhythm and 1432 patients met inclusion criteria. The median age was 69 years [IQR 59-82]; 802 (56%) male. TH was induced in 596 (42%) patients. Survival with good neurologic outcome was 14% in the group receiving TH, compared with 5% in those not treated with TH (risk difference = 8%, 95% CI 5-12%). The adjusted OR for a CPC 1 or 2 with TH was 2.9 (95% CI 1.9-4.4). CONCLUSION: Analyzing the data collected from the registry of the standard practice in a large metropolitan region, TH is associated with improved neurologic outcome in patients resuscitated from initial non-shockable rhythms in a regionalized system for post-resuscitation care.
OBJECTIVE: Therapeutic hypothermia (TH) improves neurologic outcome in patients resuscitated from ventricular fibrillation. The purpose of this study was to evaluate TH effects on neurologic outcome in patients resuscitated from a non-shockable out-of-hospital cardiac arrest rhythm. DESIGN AND SETTING: This is a retrospective cohort study of data reported to a registry in an emergency medical system in a large metropolitan region. Patients achieving field return of spontaneous circulation are transported to designated hospitals with TH protocols. PATIENTS: Patients with an initial non-shockable rhythm were identified. Patients were excluded if awake in the Emergency Department or if TH was withheld due to preexisting coma or death prior to initiation. The decision to initiate TH was determined by the treating physician. MEASUREMENTS: The primary outcome was survival with good neurologic outcome defined by a cerebral performance category of 1 or 2. MAIN RESULTS: Of the 2772 patients treated for cardiac arrest during the study period, there were 1713 patients resuscitated from cardiac arrest with an initial non-shockable rhythm and 1432 patients met inclusion criteria. The median age was 69 years [IQR 59-82]; 802 (56%) male. TH was induced in 596 (42%) patients. Survival with good neurologic outcome was 14% in the group receiving TH, compared with 5% in those not treated with TH (risk difference = 8%, 95% CI 5-12%). The adjusted OR for a CPC 1 or 2 with TH was 2.9 (95% CI 1.9-4.4). CONCLUSION: Analyzing the data collected from the registry of the standard practice in a large metropolitan region, TH is associated with improved neurologic outcome in patients resuscitated from initial non-shockable rhythms in a regionalized system for post-resuscitation care.
Authors: Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek Journal: Circulation Date: 2008-10-23 Impact factor: 29.690
Authors: Nichole Bosson; Amy H Kaji; James T Niemann; Marc Eckstein; Paula Rashi; Richard Tadeo; Deidre Gorospe; Gene Sung; William J French; David Shavelle; Joseph L Thomas; William Koenig Journal: Prehosp Emerg Care Date: 2014-01-08 Impact factor: 3.077
Authors: Christoph Testori; Fritz Sterz; Michael Holzer; Heidrun Losert; Jasmin Arrich; Harald Herkner; Danica Krizanac; Christian Wallmüller; Peter Stratil; Andreas Schober; David Hörburger; Mathias Stöckl; Christoph Weiser; Thomas Uray Journal: Resuscitation Date: 2011-11-29 Impact factor: 5.262
Authors: Melika Hosseini; Robert H Wilson; Christian Crouzet; Arya Amirhekmat; Kevin S Wei; Yama Akbari Journal: Neurotherapeutics Date: 2020-04 Impact factor: 7.620
Authors: Romergryko G Geocadin; Eelco Wijdicks; Melissa J Armstrong; Maxwell Damian; Stephan A Mayer; Joseph P Ornato; Alejandro Rabinstein; José I Suarez; Michel T Torbey; Richard M Dubinsky; Jason Lazarou Journal: Neurology Date: 2017-05-10 Impact factor: 9.910
Authors: Sini Saarinen; Ari Salo; James Boyd; Päivi Laukkanen-Nevala; Catharina Silfvast; Ilkka Virkkunen; Tom Silfvast Journal: Scand J Trauma Resusc Emerg Med Date: 2018-11-19 Impact factor: 2.953